Histone Trimethylation of the p53 Gene by Expression of a Constitutively Active Prolactin Receptor in Prostate Cancer Cells

Dun-Yong Tan; Si Tan; Jie Zhang; Pei-Zhi Tang; Jian-Jun Huang; Wei-Hua Zhou; Shi-Jun Wu

doi:10.4077/CJP.2013.BAB139

山西大学，您好！

感谢采购，人社期刊库｜人社论文库，期间：2025/01/01~2025/12/31

感谢试用，科学期刊库｜科学论文库，期间：2024/10/20~2025/01/20

浏览高级检索

关闭
检索检索高级检索出版物检索
浏览期刊主题浏览核心期刊浏览期刊拼音浏览

关闭

查询符号(半角)	查询符号意义说明
空格	表示为「AND」两个查询词之交集
双引号 ( " " )	片语以双引号标示开始及结束，而且只寻找出现顺序相同的字词，例： " image process "
?	表示一个字母切截，输入两个?表两个字母，依此类推，例：输入「Appl?」，查得结果应为appl e , appl y … ( 常用于英文字查询 )
*	表示不限字母切截，由0~n. 例：输入「appl*」，查得结果应为appl e , appl es , appl y , appl ied , appl ication … ( 常用于英文字查询 )
AND、OR、NOT	布尔逻辑组合关键字，用来扩大或缩小查询范围的技巧。 (1) AND ：缩小查询范围 (2) OR ：扩大查询范围(3) NOT：排除不相关的范围

DOI 是数位物件识别码（ D igital O bject I dentifier ）的简称，
为物件在网路上的唯一识别码，可用于永久连结并引用目标物件。

使用DOI作为永久连结

每个DOI号前面加上「 http://dx.doi.org/ 」便成为永久网址。
如以DOI号为 10.5297/ser.1201.002 的文献为例，此文献的永久连结便是： http://dx.doi.org/ 10.5297/ser.1201.002 。
日后不论出版单位如何更动此文献位置，永久连结所指向的位置皆会即时更新，不再错失重要的研究。

引用含有DOI的文献

有DOI的文献在引用时皆应同时引用DOI。若使用APA、Chicago以外未规范DOI的引用格式，可引用DOI永久连结。

DOI可强化引用精确性、增强学术圈连结，并给予使用者跨平台的良好使用经验，目前在全世界已有超过五千万个对象申请DOI。如想对DOI的使用与概念有进一步了解，请参考（）。

ACI:

数据来源：Academic Citation Index，简称ACI

台湾最大的引用文献资料库，目前收录台湾与港澳地区所出版的人文学、社会学领域学术期刊之书目资料与参考文献，总期刊量超过690种，每年定期公布收录期刊的影响指数(Impact Factor)等指标给大众，并提供专家学者与学术单位实用的计量与分析功能。

五年影响指数（5-Year Impact Factor）：某一期刊前五年所出版的文章在当年度的平均被引用次数。

公式：（前五年发表论文在统计年的被引用次数）÷（前五年论文产出论文总篇数）

例如：A期刊2017年之五年影响指数

(A期刊2012-2016年发表论文在2017年的被引总次数)/(A期刊2012-2016年发表的论文总数)

什么是预刊文章？

为提供读者最前线之学术资讯，于期刊文献获同意刊登后、纸本印制完成前，率先于网路线上发表之文章即为预刊文章。预刊文章尚未有卷期、页次及出版日期资讯，但可藉由DOI号识别。 DOI号是文献的数位身份证字号，不论预刊或正式出版皆不会改变，读者可点击DOI连结，或于DOI号前面加上「 http://dx.doi.org/ 」连结到文献目前最新版本。

如何引用预刊文章？

请使用预刊文章的线上发表日期及DOI号来引用该篇文献。

引用范例(视不同引文格式规范可能有所差异)：

作者姓名。文章篇名。期刊名称。 YYYY/MM/DD线上预先发表。

doi:DOI 号

来源数据

P282 - 290

医药卫生 > 基础医学

DOI： 10.4077/CJP

书目管理工具

相关连结

问题回报

全文下载

Histone Trimethylation of the p53 Gene by Expression of a Constitutively Active Prolactin Receptor in Prostate Cancer Cells

Dun-Yong Tan ； Si Tan ； Jie Zhang ； Pei-Zhi Tang ； Jian-Jun Huang ； Wei-Hua Zhou ； Shi-Jun Wu

The Chinese Journal of Physiology ； 56 卷 5 期 (2013 / 10 / 31) ， P282 - 290

英文 DOI： 10.4077/CJP.2013.BAB139

constitutively active prolactin receptor ； delta S2 ； histone modification ； p53 gene ； prostate cancer

1 个人觉得这篇文章赞

摘要 │ 参考文献 (32) │ 国际计量

并列摘要〈TOP〉

Prolactin (PRL) is a pituitary polypeptide hormone characterized by multiple biological actions including stimulation of growth in the prostate, breast and ovarian epithelial cells. A sizable body of reports has presented evidences to indicate the involvement of PRL in the pathogenic process of cancers of the reproductive system, such as prostate and breast cancers. PRL exerts its effects by dimerizing its receptor (PRLR) on the plasma membrane, and initiating cellular Jak-Stat signal pathway. We have previously cloned from prostate cancer cells a natural variant of PRLR in which the S2 subdomain of the extracellular domain is missing (ΔS2). Our preliminary data showed that ΔS2 PRLR was able to dimerize and to constitutively activate the β-casein promoter (in the absence of its ligand, PRL) in breast and prostate epithelial cells. Enhancer of zeste homologue 2 (EZH2), an important histone-modifying enzyme, is able to trimethylate histone 3 on lysine 27 (H3K27Me3), consequently leading to gene silencing, especially silencing of tumor suppressor genes such as p53. We hypothesized that ΔS2 PRLR played an important pathogenic role in prostate cancer through, at least partly, alterations in the expression of EZH2 and the trimethylation of histone 3 on lysine 27. In the present study, overexpression of ΔS2 PRLR in prostate epithelial cells was achieved by infection with an adenoviral vector carrying the cDNA. The viable cell number overexpressing ΔS2 PRLR was assessed using MTS reagent. Western blot, chromatin immunoprecipitation (ChIP) assay and acid histone extraction were applied to detect expression of EZH2 as well as trimethylation of histone 3, respectively. In prostate epithelial cells, overexpression of ΔS2 PRLR increased the levels of EZH2 methyltransferase mRNA and protein, induced EZH2 methyltransferase recruitment to chromatin, increased the trimethylation of histone 3 on lysine 27, and decreased expression of the p53 gene. We concluded that ΔS2 PRLR plays an important pathogenic role in prostate cancer through epigenetic covalent modification leading to chromatin remodeling. Hypertrimethylation on H3K27 of the p53 gene promoter region due to elevated expression of ΔS2 PRLR by alternative splicing of the pre-mRNA in its full-length form might serve as a new mechanism underlying human prostate cancer.

参考文献 ( 32 ) 〈TOP〉

Akkers, R.C.,Heeringen, S.J.,Jacobi, U.G.,Janssen-Megens, E.M.,Françoijs, K.J.,Stunnenberg, H.G.,Veenstra, G.J.(2009).A hierarchy of H3K4me3 and H3K27me3 acquisition in spatial gene regulation in Xenopus Embryos.Dev. Cell,17,425-434.
Bachmann, J.M.,Halvorsen, O.J.,Collett, K.,Stefansson, J.M.,Straume, O.,Haukaas, S.A.,Salvesen, H.B.,Otte, A.P.,Akslen, L.A.(2008).EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast.J. Clin. Oncol.,24,268-273.
Bracke, M.E.,Von Roy, F.M.,Mareel, M.M.(1996).The E-cadherin/catenin complex in invasion and metastasis..Curr. Top. Microbiol. Immunol.,213,123-161.
Bredfeldt, T.G.,Greathouse, K.L.,Safe, S.H.,Hung, M.C.,Bedford, M.T.,Walker, C.L.(2010).Xenoestrogen-Induced Regulation f EZH2 and histone methylation via estrogen receptor signaling to PI3K/AKT.Mol. Endocrinol.,24,993-1006.
Broutin, I.,Jomain, J.B.,Tallet, E.,Agthoven, J.V.,Raynal, B.,Hoos, S.,Kragelund, B.B.,Kelly, P.A.,Ducruix, A.,England, P.,Goffin, V.(2010).Crystal structure of an affinity-matured prolactin complexed to its dimerized receptor reveals the topology of hormone binding Site 2.J. Biol. Chem.,285,8422-8433.

国际计量

〈TOP〉

E-mail ：

文章公开取用时，将寄通知信至您填写的信箱地址